Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, hit its lower circuit at Rs 6.08, down 5% from the previous close, the maximum daily loss permitted under its 5% price band. This price band restricts the intraday fall, but the exchange floor effectively stopped the decline, not the sellers. The total traded volume was 54,710 shares, with a turnover of just ₹0.034 crore, reflecting the mechanical freeze in price movement as supply overwhelmed demand to the point where the circuit breaker intervened. The unfilled supply at the lower circuit price indicates sellers remain queued, unable to exit positions at higher levels — a common scenario in small-cap stocks where liquidity is limited. Vivimed Labs Ltd is now caught in this liquidity trap, raising questions about the depth of selling pressure and the potential for further downside.

Delivery and Volume Analysis

Delivery volumes on 5 Jun 2026 rose by 14.08% compared to the 5-day average, with 8,230 shares delivered. On a lower circuit day, rising delivery volume is a critical signal — it means holders are liquidating actual positions rather than speculative short-selling. This genuine selling pressure suggests that the decline is driven by investors offloading shares rather than intraday traders opening shorts. Despite the circuit lock limiting price movement, the delivery data reveals a capitulation phase where holders are exiting, not merely traders betting on price falls. Vivimed Labs Ltd's delivery surge on a lower circuit day raises the question is this capitulation or just the beginning for Vivimed Labs Ltd?

Intraday Price Action

The intraday range was relatively narrow, with the stock hitting a high of Rs 6.54 and a low of Rs 6.08, closing near the circuit floor at Rs 6.08. This limited range suggests that the stock opened close to the lower circuit and remained under selling pressure throughout the session, unable to recover. The absence of a rebound from higher levels indicates persistent demand absence, reinforcing the notion of unfilled supply. The stock’s inability to trade above Rs 6.54 during the day highlights the lack of buyer interest, which is critical in understanding the severity of the sell-off. Vivimed Labs Ltd's intraday price action prompts the question does the technical profile of Vivimed Labs Ltd show any nearby support, or is more downside likely?

Moving Averages and Trend Context

Vivimed Labs Ltd is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a sustained downtrend, with no immediate technical support visible from these indicators. The stock’s position below these averages signals that the lower circuit event is not an isolated incident but rather an acceleration of an existing weakness. The technical picture suggests that the stock remains vulnerable, and the circuit lock may have only temporarily halted the decline rather than signalling a reversal.

Liquidity and Exit Risk

With a market capitalisation of approximately Rs 52 crore, Vivimed Labs Ltd is classified as a micro-cap stock. Liquidity is limited, with the stock’s average traded value allowing a trade size of effectively zero rupees based on 2% of the 5-day average traded value. This near-zero liquidity means that any sizeable position faces severe exit friction, especially on a lower circuit day when sellers queue but buyers are absent. The circuit lock, while preventing further price falls, also traps sellers who cannot exit, potentially prolonging the period of price stagnation at the lower band. Vivimed Labs Ltd's micro-cap status raises the critical question how deep is the exit problem for Vivimed Labs Ltd and what would need to change for normal trading to resume?

Brief Fundamental Context

Vivimed Labs Ltd operates within the Pharmaceuticals & Drugs industry. While fundamentals are not the focus of this analysis, the micro-cap status and recent price action suggest that market sentiment is currently unfavourable. The stock’s recent performance underlines the challenges faced by smaller companies in maintaining investor confidence amid liquidity constraints.

Conclusion: Severity and Liquidity Caveats

The 5% single-day loss culminating in a lower circuit lock for Vivimed Labs Ltd reflects a significant imbalance between supply and demand, with sellers unable to find buyers at higher levels. Rising delivery volumes confirm genuine liquidation rather than speculative short-selling, while the stock’s position below all moving averages confirms a persistent downtrend. The micro-cap liquidity profile compounds the exit risk, as meaningful positions face severe friction in exiting. The circuit breaker has frozen the price but also trapped sellers, raising the question after a 5% single-day loss at lower circuit, is Vivimed Labs Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today